Literature DB >> 2669763

Alkalinization of the food vacuole of malaria parasites by quinoline drugs and alkylamines is not correlated with their antimalarial activity.

H Ginsburg1, E Nissani, M Krugliak.   

Abstract

Quinoline-containing antimalarial drugs accumulate inside the acid food vacuole of the parasite where they inhibit the digestion of ingested host cell cytosol, and consequently, parasite growth. In order to verify whether this inhibition is caused by drug-induced alkalinization of the food vacuole, we investigated the accumulation of acridine orange (AO) as a vacuolar pH probe in intact Plasmodium falciparum-infected human erythrocytes as affected by the drugs chloroquine (CQ), 7H-quinoleine (7HQ), quinine (Q) and mefloquine (MQ). It was established by various criteria that AO accumulates primarily in the acid compartment(s) of the parasite as a function of the pH difference between it and the extracellular medium. This pH gradient was dissipated by the drugs in the rank order MQ greater than CQ greater than Q greater than 7HQ. The kinetics of vacuolar alkalinization and the concentration ranges at which it was observed imply that the monoprotic drugs MQ and Q exerted their effect mostly by translocating protons across the vacuolar membrane, i.e. they could cross the membrane as a protonated species, while the diprotic drugs CQ and 7HQ raised the vacuolar pH mostly by proton trapping. Similarly, hydrophobic alkylamines raised the vacuolar pH by proton translocation, while their relatively more polar congeners and ammonia did so by proton titration. However, the alkalinizing effect of each drug was observed at a concentration which was 1-2 orders of magnitude larger than the IC50 of its antimalarial effect. These results mean that vacuolar alkalinization is not the primary effect of antiparasitic action of quinoline antimalarials.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2669763     DOI: 10.1016/0006-2952(89)90550-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Mode of action of tubulozoles against Plasmodium falciparum in vitro.

Authors:  A Dieckmann-Schuppert; R M Franklin
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

2.  Potentiation of an antimalarial oxidant drug.

Authors:  R W Winter; M Ignatushchenko; O A Ogundahunsi; K A Cornell; A M Oduola; D J Hinrichs; M K Riscoe
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

3.  PfCRT and the trans-vacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX.

Authors:  Patrick G Bray; Mathirut Mungthin; Ian M Hastings; Giancarlo A Biagini; Dauda K Saidu; Viswanathan Lakshmanan; David J Johnson; Ruth H Hughes; Paul A Stocks; Paul M O'Neill; David A Fidock; David C Warhurst; Stephen A Ward
Journal:  Mol Microbiol       Date:  2006-08-31       Impact factor: 3.501

Review 4.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

5.  Evaluation of pH during cytostomal endocytosis and vacuolar catabolism of haemoglobin in Plasmodium falciparum.

Authors:  Nectarios Klonis; Olivia Tan; Katherine Jackson; Daniel Goldberg; Michael Klemba; Leann Tilley
Journal:  Biochem J       Date:  2007-11-01       Impact factor: 3.857

6.  Antimalarial quinolines and artemisinin inhibit endocytosis in Plasmodium falciparum.

Authors:  Heinrich C Hoppe; Donelly A van Schalkwyk; Ursula I M Wiehart; Sandra A Meredith; Joanne Egan; Brandon W Weber
Journal:  Antimicrob Agents Chemother       Date:  2004-07       Impact factor: 5.191

7.  Killing of intraerythrocytic Plasmodium falciparum by lysosomotropic amino acid esters.

Authors:  Miriam Krugliak; Jianmin Zhang; Edna Nissani; Sonia Steiner-Mordoch; Hagai Ginsburg
Journal:  Parasitol Res       Date:  2003-01-08       Impact factor: 2.289

8.  Design, synthesis, and evaluation of 10-N-substituted acridones as novel chemosensitizers in Plasmodium falciparum.

Authors:  Jane X Kelly; Martin J Smilkstein; Roland A Cooper; Kristin D Lane; Robert A Johnson; Aaron Janowsky; Rozalia A Dodean; David J Hinrichs; Rolf Winter; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

Review 9.  Prioritization of Anti-SARS-Cov-2 Drug Repurposing Opportunities Based on Plasma and Target Site Concentrations Derived from their Established Human Pharmacokinetics.

Authors:  Usman Arshad; Henry Pertinez; Helen Box; Lee Tatham; Rajith K R Rajoli; Paul Curley; Megan Neary; Joanne Sharp; Neill J Liptrott; Anthony Valentijn; Christopher David; Steve P Rannard; Paul M O'Neill; Ghaith Aljayyoussi; Shaun H Pennington; Stephen A Ward; Andrew Hill; David J Back; Saye H Khoo; Patrick G Bray; Giancarlo A Biagini; Andrew Owen
Journal:  Clin Pharmacol Ther       Date:  2020-06-14       Impact factor: 6.903

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.